CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 480 enrolled
Drug / intervention
Ibuprofen +2 moredrug
Likely dose
Ibuprofen 600 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02785549
NCT02785549Phase 4Completed
CompareCT.gov

Multicentre Controlled, Randomized Clinical Trial to Compare the Efficacy and Safety of Ambulatory Treatment of Mild Acute Diverticulitis Without Antibiotics With the Standard Treatment With Antibiotics

Corporacion Parc Tauli·interventional·Posted May 30, 2016·Updated May 14, 2020

In Brief

A Phase 4 clinical trial evaluating Ibuprofen, Acetaminophen, and 1 other intervention for Acute Diverticulitis. Completed, enrolled 480 participants across 1 site.

Detailed Summary

Patients with mild acute diverticulitis (modified Neff 0 grade), following the inclusion criteria and giving informed consent, will be included in the study protocol and will be randomly assigned to one of the treatment arms: symptomatic treatment with NSAID plus antibiotic vs symptomatic treatment with NSAID only. They will be followed-up at 48 hours, 7 days, 30 days and 3 months from the onset of the episode.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Diverticulitis
CountriesSpain
Collaborators--

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedMay 30, 2016
Enrollment StartNov 1, 2016
Primary CompletionJan 12, 2020
Study CompletionApr 1, 2020
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 10.1 years ago

Interventions

Ibuprofendrug

600 mg/8hours

Acetaminophendrug

1 g/8 hours

Amoxicillin/clavulanic aciddrug

875mg/125mg/8 hours